13D/13G Filings - BICYCLE THERAPEUTICS PLC (BCYC)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
08:41 am
Sale
2024-12-31 13G Bicycle Therapeutics plc
BCYC
Deep Track Capital, LP 3,330,236
6.710%
-160,270decrease
(-4.59%)
Filing
History
2025-02-11
09:09 am
Purchase
2024-12-31 13G Bicycle Therapeutics plc
BCYC
WESTFIELD CAPITAL MANAGEMENT CO LLC 2,610,337
5.490%
2,610,337increase
(New Position)
Filing
History
2024-12-20
4:05 pm
Purchase
2024-12-13 13G Bicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P. 4,230,302
8.900%
3,209,134increase
(+314.26%)
Filing
History
2024-12-19
3:47 pm
Purchase
2024-11-21 13G Bicycle Therapeutics plc
BCYC
Forbion Growth Opportunities Fund II Cooperatief U.A. 3,452,330
7.300%
3,452,330increase
(New Position)
Filing
History
2024-12-17
6:46 pm
Purchase
2024-12-13 13D Bicycle Therapeutics plc
BCYC
Baker Bros. Advisors LP 10,885,357
22.900%
1,485,397increase
(+15.80%)
Filing
History
2024-11-14
5:46 pm
Unchanged
2024-09-30 13G Bicycle Therapeutics plc
BCYC
RA Capital Management, L.P. 2,253,000
4.700%
0
(Unchanged)
Filing
History
2024-11-14
4:32 pm
Sale
2024-09-30 13G Bicycle Therapeutics plc
BCYC
Paradigm BioCapital Advisors LP 0
0.000%
-3,707,001decrease
(Position Closed)
Filing
History
2024-11-13
9:30 pm
Sale
2024-09-30 13G Bicycle Therapeutics plc
BCYC
Jefferies Financial Group Inc.
JEF
0
0.000%
-1,948,000decrease
(Position Closed)
Filing
History
2024-06-07
4:18 pm
Purchase
2024-05-28 13G Bicycle Therapeutics plc
BCYC
RA Capital Management, L.P. 2,253,000
5.000%
2,253,000increase
(New Position)
Filing
History
2024-05-28
4:16 pm
Purchase
2024-05-23 13D Bicycle Therapeutics plc
BCYC
Baker Bros. Advisors LP 9,399,960
19.900%
1,710,717increase
(+22.25%)
Filing
History
2024-04-18
07:29 am
Purchase
2024-04-16 13D Bicycle Therapeutics plc
BCYC
Baker Bros. Advisors LP 7,689,243
19.900%
2,865,645increase
(+59.41%)
Filing
History
2024-02-14
4:08 pm
Sale
2023-12-31 13G Bicycle Therapeutics plc
BCYC
Ridgeback Capital Investments L.P. 844,235
2.200%
-1,420,566decrease
(-62.72%)
Filing
History
2024-02-14
4:08 pm
Purchase
2023-12-31 13G Bicycle Therapeutics plc
BCYC
Paradigm BioCapital Advisors LP 3,707,001
9.800%
2,096,336increase
(+130.15%)
Filing
History
2024-02-14
4:07 pm
Purchase
2023-12-31 13G Bicycle Therapeutics plc
BCYC
Jefferies Financial Group Inc.
JEF
1,948,000
5.165%
1,948,000increase
(New Position)
Filing
History
2024-02-14
08:37 am
Purchase
2023-12-31 13G Bicycle Therapeutics plc
BCYC
Deep Track Capital, LP 3,490,506
9.250%
671,461increase
(+23.82%)
Filing
History
2024-02-12
4:10 pm
Purchase
2024-01-31 13G Bicycle Therapeutics plc
BCYC
Baker Bros. Advisors LP 4,823,598
12.800%
4,823,598increase
(New Position)
Filing
History
2024-02-12
11:59 am
Sale
2023-12-31 13G Bicycle Therapeutics plc
BCYC
JANUS HENDERSON GROUP PLC
JHG
0
0.000%
-1,503,447decrease
(Position Closed)
Filing
History
2023-07-19
6:29 pm
Unchanged
2023-07-17 13D Bicycle Therapeutics plc
BCYC
GLAXOSMITHKLINE PLC 1,529,561
4.400%
0
(Unchanged)
Filing
History
2023-02-24
4:54 pm
Purchase
2023-02-14 13G Bicycle Therapeutics plc
BCYC
Paradigm BioCapital Advisors LP 1,610,665
5.400%
1,610,665increase
(New Position)
Filing
History
2023-02-14
4:09 pm
Sale
2022-12-31 13G Bicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P. 1,021,168
3.400%
-551,655decrease
(-35.07%)
Filing
History
Goto 0, 1, 2, Next